Beacon Therapeutics Secures $170 Million in Series B Funding
Key Highlights $170 million raised in Series B funding led by Forbion. Funds to support AGTC-501 clinical trials for X-Linked Retinitis Pigmentosa (XLRP).…
Browsing Tag
J.P. Morgan
2 posts
Bright Health Group Announces Sale of California Medicare Advantage Business and Strengthened Financial Position
Key Highlights Successful sale of California Medicare Advantage business: Bright Health sells Brand New Day and Central Health…